Racura Oncology Ltd | ABN 61 149 318 749 | L36 1 Macquarie Place Sydney NSW 2000 Australia +61 2 8051 3043 | [email protected] | www.racuraoncology.com 1 ASX Announcement Racura RC220 MYC-silencing data to be presented at the 2026 Frontiers in Cancer Science Conference § Poster presentation...
RC220 MYC-silencing data to be presented FCS 26 conference
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Racura Oncology
- Racura Oncology Adelaide Investor Briefing
- Notification regarding unquoted securities - RAC
- CPACS Trial Opens for RC220 Patient Enrolment in Korea
- Corporate Governance Statement
- Appendix 4G
Later from Racura Oncology
- Appendix 3Y - Dr Daniel Tillett
- Date of AGM & Closing Date for Director Nominations
- Racura Presents CPACS Data at GCOS 2026
- HARNESS-1 First Cohort Cleared
- Sept 2026 Quarterly Activities Report and Appendix 4C
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology